Search

Scientists in the two newest EU members may have more reason to cheer their accession than the farmers and labourers who were expected to benefit most.

A new report from the OECD makes uncomfortable reading for anyone in Switzerland involved in educational R&D.

Who cares about Brussels? Apparently scientists do, with over 200,000 application forms for its €4 billion fund already downloaded. What next? Commissioner Janez Potočnik wants an EU-wide debate.

Under pressure to demonstrate economic returns on research spending, the UK’s research councils are going to make academics think commercial and to cosy up to industry.

In the lean years since the post-genomics bust, venture funding has been hard to come by for Europe’s biotech start-ups. Now they have polished up their business models, and valuations are low, attracting investors back in.

In a rare example of a university tec transfer deal attracting an upfront payment, French pharma company Ipsen paying €1.25 million for a treatment licence.

The UK government has given £1.1 million to Plasticell Ltd to fund the development of a system to automate stem cell research.

Scotland is investing £9.5 million of public money in the Swedish stem cell company Cellartis AB to fund an R&D and manufacturing facility in Dundee.

Global acceptance of biotech crops increased in 2006, with acreage reaching 102 million hectares in 22 countries, according to a new report.

France’s best-known engineering school, the École Polytechnique, is mapping out a major expansion drive for the next five years.